세계의 말초용 약제용출 풍선 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Peripheral Drug Eluting Balloon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,352,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,055,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 이번에 세계의 말초용 약제용출 풍선 시장에 관한 종합적조사 리포트를 발표했습니다. 시장 성장 촉진요인·동향·시장 성장 촉진요인·과제를 포함한 중요 시장 역학을 철저히 평가하고, 시장 구조에 관한 상세 인사이트을 제공하고 있습니다.

주요 인사이트

• 말초용 약제용출 풍선 시장 규모(2024년) : 9억 4,860만 달러
• 시장 예측(2033년) : 19억 5,050만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 8.3%

말초용 약제용출 풍선 시장 - 조사 범위

말초용 약제용출 풍선은 약물을 동맥벽에 직접 전달하여 재협착을 억제하고 혈류를 개선함으로써 말초동맥질환(PAD) 치료에 중요한 역할을 합니다. 이 풍선은 병원, 클리닉, 외래 환자 센터 등 다양한 의료 환경에서 사용되고 있으며, 환자의 다양한 요구를 충족시키기 위해 다양한 약물 제형과 풍선 크기를 제공하며, PAD의 유병률 증가, 풍선 기술의 발전, 최소 침습적 치료에 대한 선호도 증가가 시장 성장의 원동력이 되고 있습니다. 시장 성장의 원동력이 되고 있습니다.

시장 성장 촉진요인 :

세계 말초용 약제용출 풍선 시장은 전 세계에서 수백만 명이 앓고 있는 PAD의 발병률 증가와 같은 몇 가지 중요한 요인에 힘입어 성장하고 있습니다. 지속적인 약물전달과 재협착률을 낮추는 효과적인 치료 옵션에 대한 수요가 약제용출 풍선의 채택을 촉진하고 있습니다. 약물 코팅 및 전달 메커니즘을 개선한 차세대 풍선 개발 등 기술 발전은 치료 효과와 환자 예후를 개선하는 데 도움이 됩니다. 또한 최소침습적 수술의 채택 증가와 유리한 상환 정책은 시장 성장에 더욱 기여하고 있습니다.

시장 성장 억제요인 :

성장 가능성이 높은 말초용 약제용출 풍선 시장은 규제 준수, 높은 비용, 신흥 시장에서의 낮은 인지도 등의 문제에 직면해 있습니다. 약제용출 풍선의 승인 및 사용에 대한 엄격한 규제는 제조업체에 큰 규제 준수 부담을 안겨주고 있습니다. 또한 특히 의료 예산이 제한된 지역에서는 약제용출 풍선 및 관련 시술의 높은 비용도 보급에 걸림돌로 작용하고 있습니다. 또한 신흥 국가에서는 PAD와 사용 가능한 치료 옵션에 대한 인식이 낮다는 점도 시장 침투에 걸림돌로 작용하고 있습니다.

시장 기회

말초용 약제용출 풍선 시장은 기술 혁신, 인구 증가, 헬스케어 인프라 확대가 큰 성장 기회로 작용하고 있습니다. 첨단 약물 제제 및 새로운 약물전달 기술을 풍선 기기에 통합함으로써 치료 결과를 개선하고 적용 범위를 확대할 수 있을 것으로 기대됩니다. 특히 신흥 국가에서는 헬스케어 인프라에 대한 투자가 증가하고 있으며, 새로운 시장 기회 창출이 기대되고 있습니다. 이러한 기회를 활용하고 시장 주도권을 유지하기 위해서는 전략적 제휴, R&D 투자, 비용 효율적인 솔루션 도입이 필수적입니다.

이 보고서에서 다룬 주요 질문

• 말초용 약제용출 풍선 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 다양한 의료 현장에서 말초용 약제용출 풍선의 채택을 촉진하는 약물 처방 및 용도는?
• 기술의 발전은 말초용 약제용출 풍선 시장 경쟁 구도를 어떻게 변화시키고 있는가?
• 말초용 약제용출 풍선 시장에 기여하는 주요 기업은 어디에 있으며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 말초용 약제용출 풍선 시장의 새로운 동향과 전망은?

목차

제1장 개요

제2장 시장 개요

• 시장 범위/ 분류
• 시장의 정의/ 범위/ 제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 약제 코팅 혁신/개발 동향

제4장 부가가치 인사이트

• 지역별 제품 채택/사용 상황 분석
• 규제 시나리오
• 기술 평가
• 밸류체인 분석
• 최근 제품 승인과 발매
• Porter's Five Forces 분석
• 제품 USP 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19로 영향 분석
  • 약제 코팅별
  • 증상별
  • 동맥 유형별
  • 최종사용자별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 수요 수량 분석

• 과거 시장 수량 분석(2019-2023년)
• 현재·향후 시장 수량 예측(2024-2033년)
  • 전년대비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 약제 코팅별 지역 가격 분석
• 가격 내역
  • 제조업체 레벨 가격결정
  • 디스트리뷰터 레벨 가격결정
• 세계 평균 가격 분석 벤치마크
• 가격결정 전제

제9장 세계 시장 수요(금액) 분석

• 과거 시장 금액 분석(2019-2023년)
• 현재·향후 시장 금액 예측(2024-2033년)
  • 전년대비 성장 동향 분석
  • 절대적 이익 기회 분석
• 매출 기회 시나리오

제10장 세계 시장 분석 : 약제 코팅별

• 서론/주요 조사 결과
• 과거 시장 규모·수량 분석 : 약제 코팅별(2019-2023년)
• 현재·향후 시장 규모·수량 분석·예측 : 약제 코팅별(2024-2033년)
  • Paclitaxel 약제 코팅
  • Sirolimus 약제 코팅
  • 기타
• 약제 코팅 시장의 매력 분석

제11장 세계 시장 분석 : 증상별

• 서론/주요 조사 결과
• 과거 시장 규모·수량 분석 : 증상별(2019-2023년)
• 현재·향후 시장 규모·수량 분석·예측 : 증상별(2024-2033년)
  • 말초 동맥 질환
  • 말초 동맥류
  • 스텐트내 재협착
  • 기타
• 증상 시장의 매력 분석

제12장 세계 시장 분석 : 동맥 유형별

• 서론/주요 조사 결과
• 과거 시장 규모·수량 분석 : 동맥 유형별(2019-2023년)
• 현재·향후 시장 규모·수량 분석·예측 : 동맥 유형별(2024-2033년)
  • 경동맥
  • Fem-Pop 동맥
  • 장골 동맥
  • Infrapop 동맥
• 동맥 유형별 시장의 매력 분석

제13장 세계 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모·수량 분석 : 최종사용자별(2019-2023년)
• 현재·향후 시장 규모·수량 분석·예측 : 최종사용자별(2024-2033년)
  • 병원
  • 외래 수술 센터/외래 환자
  • 심장 카테터 검사실
• 최종사용자별 시장의 매력 분석

제14장 세계 시장 분석 : 지역별

• 서론
• 과거 시장 규모·수량 분석 : 지역별(2019-2023년)
• 현재·향후 시장 금액·수량 분석·예측 : 지역별(2024-2033년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제15장 북미 시장 분석

제16장 라틴아메리카 시장 분석

제17장 유럽 시장 분석

제18장 동아시아 시장 분석

제19장 남아시아 시장 분석

제20장 오세아니아 시장

제21장 중동 및 아프리카 시장 분석

제22장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제23장 경쟁 분석

• 경쟁 대시보드
• 제조업체에 의한 브랜딩과 프로모션 전략
• 주요 개발 분석
• 경쟁 상세
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation(Endovastec(TM))
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE &Co. KG
  • Becton, Dickinson and Company
  • WL Gore &Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular SLU
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips NV
  • REVA Medical

제24장 사용되는 전제 조건과 두자어

제25장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Peripheral Drug Eluting Balloons Market Size (2024E): USD 948.6Million
• Projected Market Value (2033F): USD 1950.5 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 8.3%

Peripheral Drug Eluting Balloons Market - Report Scope:

Peripheral drug eluting balloons play a crucial role in the treatment of peripheral artery disease (PAD) by delivering medication directly to the arterial walls to inhibit restenosis and improve blood flow. These balloons are used in various healthcare settings, including hospitals, clinics, and outpatient centers, offering a range of drug formulations and balloon sizes to cater to different patient needs. Market growth is driven by the increasing prevalence of PAD, advancements in balloon technology, and a growing preference for minimally invasive procedures.

Market Growth Drivers:

The global peripheral drug eluting balloons market is propelled by several key factors, including the rising incidence of PAD, which affects millions of people worldwide. The demand for effective treatment options that offer sustained drug delivery and reduced restenosis rates is driving the adoption of drug eluting balloons. Technological advancements, such as the development of next-generation balloons with improved drug coatings and delivery mechanisms, enhance treatment efficacy and patient outcomes. Additionally, the increasing adoption of minimally invasive procedures and favorable reimbursement policies are further contributing to market growth.

Market Restraints:

Despite promising growth prospects, the peripheral drug eluting balloons market faces challenges related to regulatory compliance, high costs, and limited awareness in emerging markets. Stringent regulations governing the approval and use of drug eluting balloons impose significant compliance burdens on manufacturers. The high cost of these devices and associated procedures can also be a barrier to widespread adoption, particularly in regions with limited healthcare budgets. Furthermore, the lack of awareness about PAD and available treatment options in developing countries hinders market penetration.

Market Opportunities:

The peripheral drug eluting balloons market presents significant growth opportunities driven by technological innovations, demographic trends, and expanding healthcare infrastructure. The integration of advanced drug formulations and novel delivery technologies into balloon devices is expected to enhance therapeutic outcomes and broaden the application scope. Increasing investments in healthcare infrastructure, particularly in emerging economies, are anticipated to create new market opportunities. Strategic collaborations, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
• Which drug formulations and applications are driving the adoption of peripheral drug eluting balloons across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the peripheral drug eluting balloons market?
• Who are the key players contributing to the peripheral drug eluting balloons market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global peripheral drug eluting balloons market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral drug eluting balloons market, including Medtronic, B. Braun Melsungen AG, and Boston Scientific Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced drug eluting balloon solutions, including devices with enhanced drug coatings and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving peripheral drug eluting balloons landscape.

Key Companies Profiled:

• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical Inc.
• MicroPort Scientific Corporation (Endovastec(TM))
• Medtronic Plc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Becton, Dickinson and Company
• W. L. Gore & Associates Inc.
• Getinge AB
• Terumo Corp
• Kyoto Medical Planning Co Ltd
• iVascular S.L.U
• AMG International GmbH
• ENDOCOR GmbH
• Meril Life Sciences Pvt. Ltd.
• Nano Therapeutics Pvt Ltd
• Koninklijke Philips N.V.
• REVA Medical

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

• Paclitaxel Drug Coating
• Sirolimus drug Coating

Indication:

• Peripheral Arterial Disease
• Peripheral Aneurysms
• In-Stent Restenosis

Artery Type:

• Carotid Arteries
• Fem-Pop Arteries
• Iliac Arteries
• Infrapop Arteries

End User:

• Hospitals
• Ambulatory Surgical Centers/Outpatients
• Cardiac Catheterization Labs

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Drug Coating Innovation / Development Trends

4. Value Added Insights

• 4.1. Product Adoption/ Usage Analysis, by region
• 4.2. Regulatory Scenario
• 4.3. Technology Assessment
• 4.4. Value Chain Analysis
• 4.5. Recent Product Approvals and Launches
• 4.6. Porter's Analysis
• 4.7. Product USP Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Peripheral Vascular Devices Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Growth in Healthcare Spending
  • 5.2.2. Growth in Geriatric Population
  • 5.2.3. Rising Number of Peripheral Surgeries
  • 5.2.4. Technological Advancements
  • 5.2.5. Regulatory Landscape
  • 5.2.6. Cost of Procedures
  • 5.2.7. Product Adoption Rate and Demand
  • 5.2.8. Increase in Research and Development
  • 5.2.9. Pharmaceutical Industry Consolidation Activities
  • 5.2.10. Top Companies' Historical Growth
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Drug Coating
  • 6.1.2. By Indication
  • 6.1.3. By Artery Type
  • 6.1.4. By End User
  • 6.1.5. By Region
• 6.2. 2024 Market Scenario

7. Global Market Demand in Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume (Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume (Units) (Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Drug Coating
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis
• 9.3. Revenue Opportunity Scenario

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Coating

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Drug Coating, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Drug Coating, 2024-2033
  • 10.3.1. Paclitaxel Drug Coating
  • 10.3.2. Sirolimus drug Coating
  • 10.3.3. Others
• 10.4. Market Attractiveness Analysis, by Drug Coating

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2024-2033
  • 11.3.1. Peripheral Arterial Disease
  • 11.3.2. Peripheral Aneurysms
  • 11.3.3. In-Stent Restenosis
  • 11.3.4. Others
• 11.4. Market Attractiveness Analysis, by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery Type

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By Artery Type, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Artery Type, 2024-2033
  • 12.3.1. Carotid Artery
  • 12.3.2. Fem-Pop Artery
  • 12.3.3. Iliac Artery
  • 12.3.4. Infrapop Artery
• 12.4. Market Attractiveness Analysis, by Artery Type

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2024-2033
  • 13.3.1. Hospitals
  • 13.3.2. Ambulatory Surgical Centers/Outpatients
  • 13.3.3. Cardiac Catheterization Labs
• 13.4. Market Attractiveness Analysis, by End User

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
• 14.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 14.3.1. North America
  • 14.3.2. Latin America
  • 14.3.3. Europe
  • 14.3.4. South Asia
  • 14.3.5. East Asia
  • 14.3.6. Oceania
  • 14.3.7. Middle East and Africa (MEA)
• 14.4. Market Attractiveness Analysis, by Region

15. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. U.S.
    • 15.3.1.2. Canada
  • 15.3.2. By Drug Coating
  • 15.3.3. By Indication
  • 15.3.4. By Artery Type
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Drug Coating
  • 15.4.3. By Indication
  • 15.4.4. By Artery Type
  • 15.4.5. By End User
• 15.5. PESTLE Analysis
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis
• 15.9. Country Level Analysis & Forecast
  • 15.9.1. U.S. Market Analysis
    • 15.9.1.1. Introduction
    • 15.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.9.1.2.1. By Drug Coating
      • 15.9.1.2.2. By Indication
      • 15.9.1.2.3. By Artery Type
      • 15.9.1.2.4. By End User
  • 15.9.2. Canada Market Analysis
    • 15.9.2.1. Introduction
    • 15.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.9.2.2.1. By Drug Coating
      • 15.9.2.2.2. By Indication
      • 15.9.2.2.3. By Artery Type
      • 15.9.2.2.4. By End User

16. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Mexico
    • 16.3.1.2. Brazil
    • 16.3.1.3. Argentina
    • 16.3.1.4. Rest of Latin America
  • 16.3.2. By Drug Coating
  • 16.3.3. By Indication
  • 16.3.4. By Artery Type
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Drug Coating
  • 16.4.3. By Indication
  • 16.4.4. By Artery Type
  • 16.4.5. By End User
• 16.5. PESTLE Analysis
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis
• 16.9. Country Level Analysis & Forecast
  • 16.9.1. Mexico Market Analysis
    • 16.9.1.1. Introduction
    • 16.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.9.1.2.1. By Drug Coating
      • 16.9.1.2.2. By Indication
      • 16.9.1.2.3. By Artery Type
      • 16.9.1.2.4. By End User
  • 16.9.2. Brazil Market Analysis
    • 16.9.2.1. Introduction
    • 16.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.9.2.2.1. By Drug Coating
      • 16.9.2.2.2. By Indication
      • 16.9.2.2.3. By Artery Type
      • 16.9.2.2.4. By End User
  • 16.9.3. Argentina Market Analysis
    • 16.9.3.1. Introduction
    • 16.9.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.9.3.2.1. By Drug Coating
      • 16.9.3.2.2. By Indication
      • 16.9.3.2.3. By Artery Type
      • 16.9.3.2.4. By End User

17. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Germany
    • 17.3.1.2. Italy
    • 17.3.1.3. France
    • 17.3.1.4. U.K.
    • 17.3.1.5. Spain
    • 17.3.1.6. BENELUX
    • 17.3.1.7. Russia
    • 17.3.1.8. Nordic Countries
    • 17.3.1.9. Rest of Europe
  • 17.3.2. By Drug Coating
  • 17.3.3. By Indication
  • 17.3.4. By Artery Type
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Drug Coating
  • 17.4.3. By Indication
  • 17.4.4. By Artery Type
  • 17.4.5. By End User
• 17.5. PESTLE Analysis
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis
• 17.9. Country Level Analysis & Forecast
  • 17.9.1. Germany Market Analysis
    • 17.9.1.1. Introduction
    • 17.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.1.2.1. By Drug Coating
      • 17.9.1.2.2. By Indication
      • 17.9.1.2.3. By Artery Type
      • 17.9.1.2.4. By End User
  • 17.9.2. Italy Market Analysis
    • 17.9.2.1. Introduction
    • 17.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.2.2.1. By Drug Coating
      • 17.9.2.2.2. By Indication
      • 17.9.2.2.3. By Artery Type
      • 17.9.2.2.4. By End User
  • 17.9.3. France Market Analysis
    • 17.9.3.1. Introduction
    • 17.9.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.3.2.1. By Drug Coating
      • 17.9.3.2.2. By Indication
      • 17.9.3.2.3. By Artery Type
      • 17.9.3.2.4. By End User
  • 17.9.4. U.K. Market Analysis
    • 17.9.4.1. Introduction
    • 17.9.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.4.2.1. By Drug Coating
      • 17.9.4.2.2. By Indication
      • 17.9.4.2.3. By Artery Type
      • 17.9.4.2.4. By End User
  • 17.9.5. Spain Market Analysis
    • 17.9.5.1. Introduction
    • 17.9.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.5.2.1. By Drug Coating
      • 17.9.5.2.2. By Indication
      • 17.9.5.2.3. By Artery Type
      • 17.9.5.2.4. By End User
  • 17.9.6. BENELUX Market Analysis
    • 17.9.6.1. Introduction
    • 17.9.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.6.2.1. By Drug Coating
      • 17.9.6.2.2. By Indication
      • 17.9.6.2.3. By Artery Type
      • 17.9.6.2.4. By End User
  • 17.9.7. Russia Market Analysis
    • 17.9.7.1. Introduction
    • 17.9.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.7.2.1. By Drug Coating
      • 17.9.7.2.2. By Indication
      • 17.9.7.2.3. By Artery Type
      • 17.9.7.2.4. By End User
  • 17.9.8. Nordic Countries Market Analysis
    • 17.9.8.1. Introduction
    • 17.9.8.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.9.8.2.1. By Drug Coating
      • 17.9.8.2.2. By Indication
      • 17.9.8.2.3. By Artery Type
      • 17.9.8.2.4. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Drug Coating
  • 18.3.3. By Indication
  • 18.3.4. By Artery Type
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Drug Coating
  • 18.4.3. By Indication
  • 18.4.4. By Artery Type
  • 18.4.5. By End User
• 18.5. PESTLE Analysis
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis
• 18.9. Country Level Analysis & Forecast
  • 18.9.1. China Market Analysis
    • 18.9.1.1. Introduction
    • 18.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.9.1.2.1. By Drug Coating
      • 18.9.1.2.2. By Indication
      • 18.9.1.2.3. By Artery Type
      • 18.9.1.2.4. By End User
  • 18.9.2. Japan Market Analysis
    • 18.9.2.1. Introduction
    • 18.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.9.2.2.1. By Drug Coating
      • 18.9.2.2.2. By Indication
      • 18.9.2.2.3. By Artery Type
      • 18.9.2.2.4. By End User
  • 18.9.3. South Korea Market Analysis
    • 18.9.3.1. Introduction
    • 18.9.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.9.3.2.1. By Drug Coating
      • 18.9.3.2.2. By Indication
      • 18.9.3.2.3. By Artery Type
      • 18.9.3.2.4. By End User

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. India
    • 19.3.1.2. Indonesia
    • 19.3.1.3. Malaysia
    • 19.3.1.4. Thailand
    • 19.3.1.5. Rest of South Asia
  • 19.3.2. By Drug Coating
  • 19.3.3. By Indication
  • 19.3.4. By Artery Type
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Drug Coating
  • 19.4.3. By Indication
  • 19.4.4. By Artery Type
  • 19.4.5. By End User
• 19.5. PESTLE Analysis
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis
• 19.9. Country Level Analysis & Forecast
  • 19.9.1. India Market Analysis
    • 19.9.1.1. Introduction
    • 19.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.9.1.2.1. By Drug Coating
      • 19.9.1.2.2. By Indication
      • 19.9.1.2.3. By Artery Type
      • 19.9.1.2.4. By End User
  • 19.9.2. Indonesia Market Analysis
    • 19.9.2.1. Introduction
    • 19.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.9.2.2.1. By Drug Coating
      • 19.9.2.2.2. By Indication
      • 19.9.2.2.3. By Artery Type
      • 19.9.2.2.4. By End User
  • 19.9.3. Malaysia Market Analysis
    • 19.9.3.1. Introduction
    • 19.9.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.9.3.2.1. By Drug Coating
      • 19.9.3.2.2. By Indication
      • 19.9.3.2.3. By Artery Type
      • 19.9.3.2.4. By End User
  • 19.9.4. Thailand Market Analysis
    • 19.9.4.1. Introduction
    • 19.9.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.9.4.2.1. By Drug Coating
      • 19.9.4.2.2. By Indication
      • 19.9.4.2.3. By Artery Type
      • 19.9.4.2.4. By End User

20. Oceania Market 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. Australia
    • 20.3.1.2. New Zealand
  • 20.3.2. By Drug Coating
  • 20.3.3. By Indication
  • 20.3.4. By Artery Type
  • 20.3.5. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Drug Coating
  • 20.4.3. By Indication
  • 20.4.4. By Artery Type
  • 20.4.5. By End User
• 20.5. PESTLE Analysis
• 20.6. Market Trends
• 20.7. Key Market Participants - Intensity Mapping
• 20.8. Drivers and Restraints - Impact Analysis
• 20.9. Country Level Analysis & Forecast
  • 20.9.1. Australia Market Analysis
    • 20.9.1.1. Introduction
    • 20.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.9.1.2.1. By Drug Coating
      • 20.9.1.2.2. By Indication
      • 20.9.1.2.3. By Artery Type
      • 20.9.1.2.4. By End User
  • 20.9.2. New Zealand Market Analysis
    • 20.9.2.1. Introduction
    • 20.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.9.2.2.1. By Drug Coating
      • 20.9.2.2.2. By Indication
      • 20.9.2.2.3. By Artery Type
      • 20.9.2.2.4. By End User

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 21.1. Introduction
• 21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 21.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 21.3.1. By Country
    • 21.3.1.1. GCC Countries
    • 21.3.1.2. Turkey
    • 21.3.1.3. Israel
    • 21.3.1.4. South Africa
    • 21.3.1.5. North Africa
    • 21.3.1.6. Rest of Middle East and Africa
  • 21.3.2. By Drug Coating
  • 21.3.3. By Indication
  • 21.3.4. By Artery Type
  • 21.3.5. By End User
• 21.4. Market Attractiveness Analysis
  • 21.4.1. By Country
  • 21.4.2. By Drug Coating
  • 21.4.3. By Indication
  • 21.4.4. By Artery Type
  • 21.4.5. By End User
• 21.5. PESTLE Analysis
• 21.6. Market Trends
• 21.7. Key Market Participants - Intensity Mapping
• 21.8. Drivers and Restraints - Impact Analysis
• 21.9. Country Level Analysis & Forecast
  • 21.9.1. GCC Countries Market Analysis
    • 21.9.1.1. Introduction
    • 21.9.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 21.9.1.2.1. By Drug Coating
      • 21.9.1.2.2. By Indication
      • 21.9.1.2.3. By Artery Type
      • 21.9.1.2.4. By End User
  • 21.9.2. Turkey Market Analysis
    • 21.9.2.1. Introduction
    • 21.9.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 21.9.2.2.1. By Drug Coating
      • 21.9.2.2.2. By Indication
      • 21.9.2.2.3. By Artery Type
      • 21.9.2.2.4. By End User
  • 21.9.3. Israel Africa Market Analysis
    • 21.9.3.1. Introduction
    • 21.9.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 21.9.3.2.1. By Drug Coating
      • 21.9.3.2.2. By Indication
      • 21.9.3.2.3. By Artery Type
      • 21.9.3.2.4. By End User
  • 21.9.4. South Africa Market Analysis
    • 21.9.4.1. Introduction
    • 21.9.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 21.9.4.2.1. By Drug Coating
      • 21.9.4.2.2. By Indication
      • 21.9.4.2.3. By Artery Type
      • 21.9.4.2.4. By End User
  • 21.9.5. North Africa Market Analysis
    • 21.9.5.1. Introduction
    • 21.9.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 21.9.5.2.1. By Drug Coating
      • 21.9.5.2.2. By Indication
      • 21.9.5.2.3. By Artery Type
      • 21.9.5.2.4. By End User

22. Market Structure Analysis

• 22.1. Market Analysis, by Tier of Companies
• 22.2. Market Share Analysis of Top Players
• 22.3. Market Presence Analysis

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Branding and Promotional Strategies, By Manufacturers
• 23.3. Key Development Analysis
• 23.4. Competition Deep Dive
  • 23.4.1. Abbott Laboratories
    • 23.4.1.1. Overview
    • 23.4.1.2. Product Portfolio
    • 23.4.1.3. Sales Footprint
    • 23.4.1.4. Key Financials
    • 23.4.1.5. SWOT Analysis
    • 23.4.1.6. Key Developments
    • 23.4.1.7. Strategy Overview
      • 23.4.1.7.1. Marketing Strategy
      • 23.4.1.7.2. Product Strategy
      • 23.4.1.7.3. Channel Strategy
  • 23.4.2. Boston Scientific Corporation
    • 23.4.2.1. Overview
    • 23.4.2.2. Product Portfolio
    • 23.4.2.3. Sales Footprint
    • 23.4.2.4. Key Financials
    • 23.4.2.5. SWOT Analysis
    • 23.4.2.6. Key Developments
    • 23.4.2.7. Strategy Overview
      • 23.4.2.7.1. Marketing Strategy
      • 23.4.2.7.2. Product Strategy
      • 23.4.2.7.3. Channel Strategy
  • 23.4.3. Cook Medical Inc.
    • 23.4.3.1. Overview
    • 23.4.3.2. Product Portfolio
    • 23.4.3.3. Sales Footprint
    • 23.4.3.4. Key Financials
    • 23.4.3.5. SWOT Analysis
    • 23.4.3.6. Key Developments
    • 23.4.3.7. Strategy Overview
      • 23.4.3.7.1. Marketing Strategy
      • 23.4.3.7.2. Product Strategy
      • 23.4.3.7.3. Channel Strategy
  • 23.4.4. MicroPort Scientific Corporation (Endovastec(TM))
    • 23.4.4.1. Overview
    • 23.4.4.2. Product Portfolio
    • 23.4.4.3. Sales Footprint
    • 23.4.4.4. Key Financials
    • 23.4.4.5. SWOT Analysis
    • 23.4.4.6. Key Developments
    • 23.4.4.7. Strategy Overview
      • 23.4.4.7.1. Marketing Strategy
      • 23.4.4.7.2. Product Strategy
      • 23.4.4.7.3. Channel Strategy
  • 23.4.5. Medtronic Plc.
    • 23.4.5.1. Overview
    • 23.4.5.2. Product Portfolio
    • 23.4.5.3. Sales Footprint
    • 23.4.5.4. Key Financials
    • 23.4.5.5. SWOT Analysis
    • 23.4.5.6. Key Developments
    • 23.4.5.7. Strategy Overview
      • 23.4.5.7.1. Marketing Strategy
      • 23.4.5.7.2. Product Strategy
      • 23.4.5.7.3. Channel Strategy
  • 23.4.6. Cardinal Health, Inc.
    • 23.4.6.1. Overview
    • 23.4.6.2. Product Portfolio
    • 23.4.6.3. Sales Footprint
    • 23.4.6.4. Key Financials
    • 23.4.6.5. SWOT Analysis
    • 23.4.6.6. Key Developments
    • 23.4.6.7. Strategy Overview
      • 23.4.6.7.1. Marketing Strategy
      • 23.4.6.7.2. Product Strategy
      • 23.4.6.7.3. Channel Strategy
  • 23.4.7. B. Braun Melsungen AG
    • 23.4.7.1. Overview
    • 23.4.7.2. Product Portfolio
    • 23.4.7.3. Sales Footprint
    • 23.4.7.4. Key Financials
    • 23.4.7.5. SWOT Analysis
    • 23.4.7.6. Key Developments
    • 23.4.7.7. Strategy Overview
      • 23.4.7.7.1. Marketing Strategy
      • 23.4.7.7.2. Product Strategy
      • 23.4.7.7.3. Channel Strategy
  • 23.4.8. BIOTRONIK SE & Co. KG
    • 23.4.8.1. Overview
    • 23.4.8.2. Product Portfolio
    • 23.4.8.3. Sales Footprint
    • 23.4.8.4. Key Financials
    • 23.4.8.5. SWOT Analysis
    • 23.4.8.6. Key Developments
    • 23.4.8.7. Strategy Overview
      • 23.4.8.7.1. Marketing Strategy
      • 23.4.8.7.2. Product Strategy
      • 23.4.8.7.3. Channel Strategy
  • 23.4.9. Becton, Dickinson and Company
    • 23.4.9.1. Overview
    • 23.4.9.2. Product Portfolio
    • 23.4.9.3. Sales Footprint
    • 23.4.9.4. Key Financials
    • 23.4.9.5. SWOT Analysis
    • 23.4.9.6. Key Developments
    • 23.4.9.7. Strategy Overview
      • 23.4.9.7.1. Marketing Strategy
      • 23.4.9.7.2. Product Strategy
      • 23.4.9.7.3. Channel Strategy
  • 23.4.10. W. L. Gore & Associates Inc.
    • 23.4.10.1. Overview
    • 23.4.10.2. Product Portfolio
    • 23.4.10.3. Sales Footprint
    • 23.4.10.4. Key Financials
    • 23.4.10.5. SWOT Analysis
    • 23.4.10.6. Key Developments
    • 23.4.10.7. Strategy Overview
      • 23.4.10.7.1. Marketing Strategy
      • 23.4.10.7.2. Product Strategy
      • 23.4.10.7.3. Channel Strategy
  • 23.4.11. Getinge AB
    • 23.4.11.1. Overview
    • 23.4.11.2. Product Portfolio
    • 23.4.11.3. Sales Footprint
    • 23.4.11.4. Key Financials
    • 23.4.11.5. SWOT Analysis
    • 23.4.11.6. Key Developments
    • 23.4.11.7. Strategy Overview
      • 23.4.11.7.1. Marketing Strategy
      • 23.4.11.7.2. Product Strategy
      • 23.4.11.7.3. Channel Strategy
  • 23.4.12. Terumo Corp
    • 23.4.12.1. Overview
    • 23.4.12.2. Product Portfolio
    • 23.4.12.3. Sales Footprint
    • 23.4.12.4. Key Financials
    • 23.4.12.5. SWOT Analysis
    • 23.4.12.6. Key Developments
    • 23.4.12.7. Strategy Overview
      • 23.4.12.7.1. Marketing Strategy
      • 23.4.12.7.2. Product Strategy
      • 23.4.12.7.3. Channel Strategy
  • 23.4.13. Kyoto Medical Planning Co Ltd
    • 23.4.13.1. Overview
    • 23.4.13.2. Product Portfolio
    • 23.4.13.3. Sales Footprint
    • 23.4.13.4. Key Financials
    • 23.4.13.5. SWOT Analysis
    • 23.4.13.6. Key Developments
    • 23.4.13.7. Strategy Overview
      • 23.4.13.7.1. Marketing Strategy
      • 23.4.13.7.2. Product Strategy
      • 23.4.13.7.3. Channel Strategy
  • 23.4.14. iVascular S.L.U
    • 23.4.14.1. Overview
    • 23.4.14.2. Product Portfolio
    • 23.4.14.3. Sales Footprint
    • 23.4.14.4. Key Financials
    • 23.4.14.5. SWOT Analysis
    • 23.4.14.6. Key Developments
    • 23.4.14.7. Strategy Overview
      • 23.4.14.7.1. Marketing Strategy
      • 23.4.14.7.2. Product Strategy
      • 23.4.14.7.3. Channel Strategy
  • 23.4.15. AMG International GmbH
    • 23.4.15.1. Overview
    • 23.4.15.2. Product Portfolio
    • 23.4.15.3. Sales Footprint
    • 23.4.15.4. Key Financials
    • 23.4.15.5. SWOT Analysis
    • 23.4.15.6. Key Developments
    • 23.4.15.7. Strategy Overview
      • 23.4.15.7.1. Marketing Strategy
      • 23.4.15.7.2. Product Strategy
      • 23.4.15.7.3. Channel Strategy
  • 23.4.16. ENDOCOR GmbH
    • 23.4.16.1. Overview
    • 23.4.16.2. Product Portfolio
    • 23.4.16.3. Sales Footprint
    • 23.4.16.4. Key Financials
    • 23.4.16.5. SWOT Analysis
    • 23.4.16.6. Key Developments
    • 23.4.16.7. Strategy Overview
      • 23.4.16.7.1. Marketing Strategy
      • 23.4.16.7.2. Product Strategy
      • 23.4.16.7.3. Channel Strategy
  • 23.4.17. Meril Life Sciences Pvt. Ltd.
    • 23.4.17.1. Overview
    • 23.4.17.2. Product Portfolio
    • 23.4.17.3. Sales Footprint
    • 23.4.17.4. Key Financials
    • 23.4.17.5. SWOT Analysis
    • 23.4.17.6. Key Developments
    • 23.4.17.7. Strategy Overview
      • 23.4.17.7.1. Marketing Strategy
      • 23.4.17.7.2. Product Strategy
      • 23.4.17.7.3. Channel Strategy
  • 23.4.18. Nano Therapeutics Pvt Ltd
    • 23.4.18.1. Overview
    • 23.4.18.2. Product Portfolio
    • 23.4.18.3. Sales Footprint
    • 23.4.18.4. Key Financials
    • 23.4.18.5. SWOT Analysis
    • 23.4.18.6. Key Developments
    • 23.4.18.7. Strategy Overview
      • 23.4.18.7.1. Marketing Strategy
      • 23.4.18.7.2. Product Strategy
      • 23.4.18.7.3. Channel Strategy
  • 23.4.19. Koninklijke Philips N.V.
    • 23.4.19.1. Overview
    • 23.4.19.2. Product Portfolio
    • 23.4.19.3. Sales Footprint
    • 23.4.19.4. Key Financials
    • 23.4.19.5. SWOT Analysis
    • 23.4.19.6. Key Developments
    • 23.4.19.7. Strategy Overview
      • 23.4.19.7.1. Marketing Strategy
      • 23.4.19.7.2. Product Strategy
      • 23.4.19.7.3. Channel Strategy
  • 23.4.20. REVA Medical
    • 23.4.20.1. Overview
    • 23.4.20.2. Product Portfolio
    • 23.4.20.3. Sales Footprint
    • 23.4.20.4. Key Financials
    • 23.4.20.5. SWOT Analysis
    • 23.4.20.6. Key Developments
    • 23.4.20.7. Strategy Overview
      • 23.4.20.7.1. Marketing Strategy
      • 23.4.20.7.2. Product Strategy
      • 23.4.20.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

관련자료